ARCHIVES

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

This article is from The Cancer Letter archive.

Vol. 20 No. 21 | May 27, 1994

Download PDF Visit The Full Archive

Related Articles

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed

August 20, 1976

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009